Research at MD Anderson
Scroll Ahead
Research with one goal: end cancer
At MD Anderson, some of the best minds in the world work in partnership with our patients to enable groundbreaking research to better treat and prevent cancer. Here, researchers have the freedom and support to follow a hypothesis and test new theories that can yield breakthroughs that transform the field and the lives of patients. Embedded in the fourth largest U.S. city – and the most ethnically diverse – our teams work with our neighbors in the Texas Medical Center, the world’s largest medical center, and around the world to advance our science and to serve our patients. From the first spark of an idea to its translation in our world-leading clinics, we remain invested and determined in our collective focus to end cancer.
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer. MD Anderson's reach is comprehensive when it comes to eliminating cancer.
Research Highlights
TCR therapy
Microbiome treatment
AAAS fellows
Messenger RNA
Pancreatic cancer study
Myelofibrosis therapy
EGFR classification
ASH 2022
Why research at MD Anderson
195
patents awarded to MD Anderson
1,300
active clinical trials
$1B+
invested in research
MD Anderson's FY21 annual report highlights the impactful research being conducted here, as well as how the organization is continuing its forward momentum in 2022 and beyond.
View more MD Anderson quick factsResearch Areas
Since 1941, MD Anderson has been home to some of the brightest minds across a variety of cancer research areas.
Resources
MD Anderson provides research tools and resources to fuel the discoveries of our scientists.
NIH Funding
MD Anderson's research and training are aided by more than $168 million in NIH grant funding, which helps power our mission to end cancer.
View our NIH award summaryCollaborative research transforms cancer care
From unlocking the secrets of the tumor microenvironment to advancing new therapies to FDA approval, MD Anderson researchers are driven by a shared goal to end cancer. As some of the top minds in the world, their groundbreaking research is shaping the future of the field and transforming cancer care.
These breakthroughs are possible because of MD Anderson’s unique research environment, which allows new insights to move seamlessly from the lab to the clinic and back. This ongoing cycle of innovation and collaboration makes MD Anderson an ideal environment to achieve progress at an unmatched pace.
Here are 22 impactful MD Anderson research accomplishments from this past year.